Young James Emmett (CIK 2050748) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-05-21). Recent activity: Buy TLSI (13,175 shares), Buy TLSI (14,762 shares), Buy TLSI (6,000 shares), Buy TLSI (12,500 shares), Buy TLSI (24,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-21 | TriSalus Life Sciences, Inc. (TLSI) | Chief Financial Officer | Buy | 13,175 | $68,246 |
| 2025-02-19 | TriSalus Life Sciences, Inc. (TLSI) | Chief Financial Officer | Buy | 14,762 | $0 |
| 2025-02-06 | TriSalus Life Sciences, Inc. (TLSI) | Chief Financial Officer | Buy | 6,000 | $33,900 |
| 2025-01-29 | TriSalus Life Sciences, Inc. (TLSI) | Chief Financial Officer | Buy | 12,500 | $0 |
| 2025-01-29 | TriSalus Life Sciences, Inc. (TLSI) | Chief Financial Officer | Buy | 24,000 | $129,600 |
Source: SEC Form 4 filings · as of 2025-05-21